Industryweek 6168 Actavis 1

Actavis Buys Forest Laboratories for $25 Billion

Feb. 18, 2014
The new group would have combined annual revenues of more than $15 billion anticipated for 2015.

DUBLIN -- Actavis (IW 1000/675), the U.S. drug firm based in Dublin, has agreed to buy Forest Laboratories (IW 500/211) for $25 billion creating a new force in several sectors, they announced on Tuesday.

"If successfully completed, the (shares and cash) transaction will combine two of the world's fastest-growing speciality pharmaceutical companies," they said.

The new group would have combined annual revenues of more than $15 billion anticipated for 2015," a joint statement said.

They said that a combined company would create blockbuster product franchises for treating the central nervous system, gastroenterology, women's health, urology and cardiovascular issues.

"Bolstered by one of the deepest and most diversified product portfolios in the industry with an exceptionally strong pipeline, this transaction creates a powerful engine for generating long-term, double-digit revenue and earnings growth," said Actavis chief executive Paul Bisaro.

The deal is worth $89.48 per Forest share, or $26.04 in cash and 0.3306 Actavis shares for each Forest stock.

Copyright Agence France-Presse, 2014

Popular Sponsored Recommendations

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Learn How Manufacturers like 3M Cater to Digital Buyers to Increase Sales

Aug. 13, 2023
In this article, you'll learn how manufacturers can balance educating and guiding their buyers through their complex buying process with a digital first approach to product discovery...

The Benefits of Continuous Thermal Monitoring

Oct. 17, 2023
Read this eBook to learn more about collecting and using data intelligently to improve performance.

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!